 |
市場調查報告書
商品編碼
1567167
胞外體診斷和治療市場：按類型、按產品和服務、按來源、按應用、按最終用戶、按地區Exosomes Diagnostic and Therapeutic Market, By Type, By Product & Service, By Source, By Application, By End User, By Geography |
||||||
全球胞外體診斷和治療市場預計到2024年將達到7,820萬美元，預計到2031年將達到2.561億美元，2024年至2031年的複合年成長率為18.5%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 7820 萬美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024年至2031年 |
| 預測 2024-2031 年複合年成長率： | 18.50% | 2031年價值預測 | 2.561 億美元 |
近年來，全球胞外體診斷和治療市場經歷了顯著成長。胞外體是奈米大小的細胞外囊泡，可作為蛋白質、脂質和核酸等生物分子的載體。它在細胞間通訊和免疫反應中發揮重要作用。胞外體在癌症、神經系統疾病和心血管疾病等各種疾病的診斷和治療中的日益成長的應用正在推動該市場的成長。研發和醫療保健行業的參與者擴大利用胞外體的潛力來開發微創液態切片、藥物輸送解決方案和再生療法。分離和表徵技術的進步正在進一步擴大胞外體的研究和臨床應用範圍。
市場動態：
推動胞外體診斷和治療市場的關鍵因素包括對非侵入性診斷的需求不斷成長、目標疾病盛行率的增加、基於胞外體的療法相對於傳統藥物的優越性以及我可以列出的技術進步。然而，與分離技術和表徵工具相關的高成本和缺乏標準化正在限制市場成長。從積極的一面來看，准入的改善和持續的完善正在創造新的機會。抗衰老藥物、不孕症治療和感染疾病控制的新應用也充滿希望。
本研究的主要特點
該報告對全球胞外體診斷和治療市場進行了詳細分析，並列出了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
它揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、業績和策略等參數對全球胞外體診斷和治療市場的主要企業進行了分析。
本研究涵蓋的主要企業包括 Evox Therapeutics Ltd、Exosome Diagnostics、Aethlon Medical、NanoSomix Inc、Thermo Fisher Scientific、Malvern Panalytical 和 System Biosciences LLC。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球胞外體診斷和治療市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球胞外體診斷和治療市場的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
第 4 章 全球胞外體診斷與治療市場，按類型，2024-2031 年（百萬美元）
- 胞外體診斷
- 胞外體療法
第5章 全球胞外體診斷與治療市場，依產品與服務分類，2024-2031 年（百萬美元）
- 設備和服務
- 試劑套件和試劑
第6章 全球胞外體診斷與治療市場，依來源分類，2024-2031 年（百萬美元）
- 幹細胞
- 血液和血漿
- 尿
- 其他資訊來源
第7章 全球胞外體診斷與治療市場，依應用分類，2024-2031 年（百萬美元）
- 癌症
- 皮膚病
- 肌肉骨骼疾病
- 心血管疾病
- 其他
第 8 章 全球胞外體診斷與治療市場，依最終使用者分類，2024-2031 年（百萬美元）
- 醫院和診斷中心
- 診所和醫生的治療環境
- 學術研究所
- 合約調查機構
- 其他
第9章全球胞外體診斷與治療市場，按地區，2019-2031，價值（百萬美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第10章競爭格局
- Thermo Fisher Scientific
- NanoSomix
- NX Pharmagen
- Malvern Instruments
- Capricor Therapeutic
- Exosome Diagnostics
- Exiqon A/S
- System Biosciences
- Exosome Sciences
- Aegle Therapeutic
- AMS Biotechnology
- Miltenyi Biotec
- Codiak BioSciences Inc.
- Lonza Group（HansaBioMed Life Sciences Ltd.）
- AcouSort AB
- Aethlon Medical, Inc.
- AGC Biologics
- Anjarium Biosciences AG
- Aruna Bio
- Brexogen
- Capricor Therapeutics
- Cells for Cells
- Ciloa
- ConvEyXO
第11章分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第12章參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
The Global Exosomes Diagnostic and Therapeutic Market is estimated to be valued at USD 78.2 Mn in 2024 and is expected to reach USD 256.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 18.5% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 78.2 Mn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 18.50% | 2031 Value Projection: | US$ 256.1 Mn |
The global exosomes diagnostic and therapeutic market has been witnessing significant growth in the recent years. Exosomes are nano-sized extracellular vesicles that act as carriers of biomolecules like proteins, lipids, and nucleic acids. They play an important role in cell-to-cell communication and immune response. The growing application of exosomes in diagnosis and treatment of various diseases like cancer, neurological disorders, and cardiovascular conditions is driving the growth of this market. Researchers and healthcare industry players are increasingly leveraging the potential of exosomes for developing minimally invasive liquid biopsies, drug delivery solutions, and regenerative therapies. Advancements in isolation and characterization techniques are further expanding the scope of research as well as clinical use of exosomes.
Market Dynamics:
The key drivers propelling the exosomes diagnostic and therapeutic market include growing demand for non-invasive diagnostic methods, increasing prevalence of target diseases, advantages of exosome-based therapies over conventional drugs, and technological advancements. However, high costs associated with isolation techniques and characterization tools, as well as lack of standardization are limiting the market growth. On the positive side, improved access and ongoing refinements are creating new opportunities. Emerging applications in anti-aging therapeutics, fertility management, and infection control also hold promise.
Key features of the study:
This report provides in-depth analysis of the global exosomes diagnostic and therapeutic market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global exosomes diagnostic and therapeutic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Evox Therapeutics Ltd, Exosome Diagnostics, Aethlon Medical, NanoSomix Inc, Thermo Fisher Scientific, Malvern Panalytical, System Biosciences LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global exosomes diagnostic and therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes diagnostic and therapeutic market.
Detailed Segmentation:
- By Type Insights (Revenue, USD Mn, 2019 - 2031)
- Exosome Diagnostics
- Exosome Therapeutics
- By Product & Service Insights (Revenue, USD Mn, 2019 - 2031)
- Instruments & Services
- Kits & Reagents
- By Source Insights (Revenue, USD Mn, 2019 - 2031)
- Stem Cells
- Blood & Blood Plasma
- Urine
- Other Sources
- By Application Insights (Revenue, USD Mn, 2019 - 2031)
- Cancer
- Dermatological Diseases
- Musculoskeletal Disorders
- Cardiovascular Diseases
- Others
- By End User Insights (Revenue, USD Mn, 2019 - 2031)
- Hospitals & Diagnostic Centers
- Clinics and Physician Settings
- Academic and Research Institutions
- Contract Research Organizations
- Others
- By Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- NanoSomix
- NX Pharmagen
- Malvern Instruments
- Capricor Therapeutic
- Exosome Diagnostics
- Exiqon A/S
- System Biosciences
- Exosome Sciences
- Aegle Therapeutic
- AMS Biotechnology
- Miltenyi Biotec
- Codiak BioSciences Inc.
- Lonza Group (HansaBioMed Life Sciences Ltd.)
- AcouSort AB
- Aethlon Medical, Inc.
- AGC Biologics
- Anjarium Biosciences AG
- Aruna Bio
- Brexogen
- Capricor Therapeutics
- Cells for Cells
- Ciloa
- ConvEyXO
Table of Contents
1. RESEARCH OBJECTIVES AND ASSUMPTIONS
- Research Objectives
- Assumptions
- Abbreviations
2. MARKET PURVIEW
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Exosomes Diagnostic and Therapeutic Market, By Type
- Global Exosomes Diagnostic and Therapeutic Market, By Product & Service
- Global Exosomes Diagnostic and Therapeutic Market, By Source
- Global Exosomes Diagnostic and Therapeutic Market, By Application
- Global Exosomes Diagnostic and Therapeutic Market, By End User
- Global Exosomes Diagnostic and Therapeutic Market, By Region
3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Exosomes Diagnostic and Therapeutic Market, By Type, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Exosome Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Exosome Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global Exosomes Diagnostic and Therapeutic Market, By Product & Service, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Instruments & Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Kits & Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Exosomes Diagnostic and Therapeutic Market, By Source, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Blood & Blood Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Other Sources
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Exosomes Diagnostic and Therapeutic Market, By Application, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Dermatological Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global Exosomes Diagnostic and Therapeutic Market, By End User, 2024-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospitals & Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Clinics and Physician Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
9. Global Exosomes Diagnostic and Therapeutic Market, By Region, 2019 - 2031, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Product & Service, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. COMPETITIVE LANDSCAPE
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NanoSomix
- NX Pharmagen
- Malvern Instruments
- Capricor Therapeutic
- Exosome Diagnostics
- Exiqon A/S
- System Biosciences
- Exosome Sciences
- Aegle Therapeutic
- AMS Biotechnology
- Miltenyi Biotec
- Codiak BioSciences Inc.
- Lonza Group (HansaBioMed Life Sciences Ltd.)
- AcouSort AB
- Aethlon Medical, Inc.
- AGC Biologics
- Anjarium Biosciences AG
- Aruna Bio
- Brexogen
- Capricor Therapeutics
- Cells for Cells
- Ciloa
- ConvEyXO
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
外泌體的全球市場 - 市場規模，預測，實驗，趨勢 (2024年)
胞外體市場規模、佔有率、趨勢分析報告：按產品/服務、按工作流程、按應用、按最終用途、按地區、細分市場預測，2024-2030
全球外泌體市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測
全球外泌體技術市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測
外泌體分離市場 - 2024-2034 年全球產業分析、規模、佔有率、成長、趨勢與預測
全球外泌體研究市場評估：依產品和服務、依適應症類型、依應用類型、依最終用戶、依地區、機會、預測（2017-2031）
胞外體研究市場：按產品/服務、適應症、應用和最終用戶 - 2024-2030 年全球預測
外泌體治療市場 - 全球產業規模、佔有率、趨勢、機會和預測，按外泌體類型、來源、治療、應用、最終用戶、地區和競爭細分，2019-2029F
胞外體研究的全球市場（~2028）：產品和服務（套件、試劑（抗體、分離和精製）、設備）、適應症（癌症、感染疾病）、用途（生物標記、疫苗）、製造服務（幹細胞））其他
外泌體技術服務的全球市場的考察，預測(～2029年)